| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/11/2003 | US6518295 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
| 02/11/2003 | US6518293 Anti-HIV imidazolone derivatives |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518282 4-Arylpiperidine derivatives for the treatment of pruritus |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518273 2-aryl indole derivative as antagonists of tachykinins |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
| 02/11/2003 | CA2222851C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2003010161A1 S-6-hydroxy-buspirone |
| 02/06/2003 | WO2003010160A2 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010146A1 Compositions derived from quinoline and quinoxaline, preparation and use thereof |
| 02/06/2003 | WO2003010145A1 Biphenyl-substituted 4-hydroxy-quinolones and their use as pesticides and herbicides |
| 02/06/2003 | WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure |
| 02/06/2003 | WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 02/06/2003 | WO2003009851A1 R-6-hydroxy-buspirone |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2003009846A1 Novel substituted benzimidazole dosage forms and method of using same |
| 02/06/2003 | WO2003009845A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 02/06/2003 | WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 02/06/2003 | WO2002096420A3 Method for treating nerve injury caused by surgery |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002070516A3 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 02/06/2003 | WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002053555A3 Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002041843A3 Antiinflammation agents |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | WO2002010137A9 Indazole derivatives as jnk inhibitors |
| 02/06/2003 | US20030028030 Oxidation of a thioether to a sulfoxide using sodium percarbonate and a molybdenum salt as catalyst; making lansoprazole, omeprazole, rabeprazole, and pantoprazole |
| 02/06/2003 | US20030028028 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030028025 Pediatric formulation of gatifloxacin |
| 02/06/2003 | US20030028022 Preferably tertiary amines comprising tetrahydroquinoline and benzimidazole; use treating human immunodeficiency virus (HIV) and Feline Immunodeficiency Virus (FIV) |
| 02/06/2003 | US20030028021 Chemical compounds |
| 02/06/2003 | US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer |
| 02/06/2003 | US20030027850 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2003 | US20030027839 Farnesyl protein transferase inhiitors for treating breast cancer |
| 02/06/2003 | US20030027838 Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone |
| 02/06/2003 | US20030027836 Arylalkoxy-substituted tetrahydroisoquinoline-3-carboxylic acids or esters |
| 02/06/2003 | US20030027831 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases |
| 02/06/2003 | US20030027823 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 02/06/2003 | US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 02/06/2003 | US20030027810 Nicotine receptor ligands |
| 02/06/2003 | US20030027808 Imidazoly-5-yl)methyl-2-quinolinone derivatives, together with platinum coordination compound selected from cisplatin or carboplatin; useful as anticarcinogenic agent |
| 02/06/2003 | US20030027797 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
| 02/06/2003 | US20030027795 N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | US20030027357 ECL labels having improved non-specific binding properties, methods of using and kits containing the same |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/05/2003 | EP1280801A2 Hydantoin-containing glucokinase activators |
| 02/05/2003 | EP1280799A1 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 02/05/2003 | EP1280798A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280794A1 Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280781A1 5-ht 7 receptor antagonists |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280773A1 5-aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres |
| 02/05/2003 | EP1280765A2 Fluorous tagging compounds and their use |
| 02/05/2003 | EP1280572A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280570A2 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280569A1 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1280568A1 Delivery devices for treatment of vascular disease |
| 02/05/2003 | EP1280512A2 Delivery systems for treatment of vascular disease |
| 02/05/2003 | EP1117653B1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | EP0984960B1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | EP0841903B1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 02/05/2003 | EP0817632B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/05/2003 | CN1395575A Novel piperidine compounds and drugs containing the same |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395486A Drug combination for treatment of depression and related disorders comprising mirtazapine and gepirone |
| 02/05/2003 | CN1394855A Substituted heterocyclic compound |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100776C Process for preparing magnesium salt of substituted sulphinyl heterocycle |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100763C Process for producing imidazole derivatives |
| 02/05/2003 | CN1100761C Benzyloxy substituted aryl copounds and their use as fungicides and insecticides |
| 02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
| 02/05/2003 | CN1100758C Process for preparing [(5,6-dicarboxy 3-pyridyl) methyl] ammonium halides |